|Bid||43.83 x 3200|
|Ask||44.02 x 2200|
|Day's range||43.73 - 44.60|
|52-week range||40.94 - 61.71|
|Beta (5Y monthly)||0.65|
|PE ratio (TTM)||8.51|
|Earnings date||01 Nov 2022|
|Forward dividend & yield||1.60 (3.66%)|
|Ex-dividend date||03 Nov 2022|
|1y target est||56.81|
What's better than a growth stock that's performed well in the past? The answer is easy: A growth stock that should perform well in the future. Here's why they chose Eli Lilly (NYSE: LLY), Pfizer (NYSE: PFE), and Vertex Pharmaceuticals (NASDAQ: VRTX).
Biohaven Pharmaceuticals (BHVN) suffers a setback as verdiperstat fails to meet the primary and secondary endpoints in an ALS study.
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?